Kaye Mark 4
4 · Elevance Health, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Kaye Mark
EVP & CFO
Transactions
- Tax Payment
Common Stock
[F1]2026-03-02$294.07/sh−271$79,693→ 15,811 total - Award
Common Stock
[F2]2026-03-02+6,377→ 22,188 total - Award
Common Stock
[F3]2026-03-02+10,202→ 32,390 total - Tax Payment
Common Stock
[F1]2026-03-03$284.03/sh−353$100,263→ 32,037 total - Award
Employee Stock Option (Right to Buy)
[F4]2026-03-02+25,188→ 25,188 totalExercise: $294.07Exp: 2036-03-02→ Common Stock (25,188 underlying)
Footnotes (4)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 2,125 shares on 3/2/2027, and 2,126 shares each on 3/2/2028 and 3/2/2029.
- [F3]Represents restricted share units. Restrictions lapse as follows: 5,101 shares each on 3/2/2027 and 3/2/2028.
- [F4]The option represents a right to purchase a total of 25,188 shares, and is exercisable in three annual installments, each installment of 8,396 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.
Signature
/s/ Kathleen S. Kiefer, Attorney in fact|2026-03-04